A review of how far GLP-1 agonists have come – drugs for type 2 diabetes that help with not only blood sugar management, but with weight loss and heart health too GLP-1 agonists entered the type 2 ...

T1D Scout founder Yuta Matsuda explains how the swab-based, at-home genetic testing he developed works – and how it can help more families access type 1 diabetes screening. Type 1 diabetes screening ...

Because GLP-1 receptor agonists slow down digestion, they may delay the absorption of oral medications like birth control pills, which could affect ovulation and fertility. As more people begin taking ...

Microdosing is the off-label use of GLP-1 receptor agonists at doses lower than those approved for the treatment of diabetes or obesity. There are numerous reasons people may explore microdosing, ...

Physical activity is an important part of blood sugar management but there are barriers to getting enough, a big one being a fear of hypoglycemia. AID systems have helped make exercise safer for ...

Many important molecules in the body are peptides. Some peptides, like GLP-1, can be modified into effective medications for a variety of conditions, including diabetes. Recently, health, wellness, ...

Here are some of the top technology highlights covered at the American Diabetes Association's 2026 scientific conference in New Orleans. Broadening access to diabetes technology and developing new ...

GLP-1-based medications have revolutionized blood sugar and weight management, but they aren’t effective for everyone. Eli Lilly, which makes the GLP-1/GIP drug Mounjaro (tirzepatide), is currently ...

The American Diabetes Association (ADA) recently released their 2025 Standards of Care, which – for the first time – includes recommendations for CGM use in type 2 diabetes, the use of GLP-1 drugs for ...